表紙:タンパク質治療薬の世界市場(2022年~2028年):COVID-19の影響分析、治療別、製品別、機能別、地域別 - 業界分析、市場規模、市場シェア、予測
市場調査レポート
商品コード
1174542

タンパク質治療薬の世界市場(2022年~2028年):COVID-19の影響分析、治療別、製品別、機能別、地域別 - 業界分析、市場規模、市場シェア、予測

Protein Therapeutics Market with COVID-19 Impact Analysis, By Therapy, By Product, Function, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2022-2028

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 288 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.87円
タンパク質治療薬の世界市場(2022年~2028年):COVID-19の影響分析、治療別、製品別、機能別、地域別 - 業界分析、市場規模、市場シェア、予測
出版日: 2022年12月01日
発行: AnalystView Market Insights
ページ情報: 英文 288 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のタンパク質治療薬の市場規模は、2021年に2,907億180万米ドルとなり、2022年~2028年の予測期間中に8.2%のCAGRで拡大すると予想されています。

当レポートでは、世界のタンパク質治療薬市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 タンパク質治療薬市場:概要

第2章 エグゼクティブサマリー

  • 市場内訳
    • 治療別
    • 製品別
    • 機能別
    • 国別
    • 地域別
  • 競合考察

第3章 タンパク質治療薬市場:主要な動向

  • 市場促進要因
    • 市場促進要因の影響分析
  • 市場抑制要因
    • 市場抑制要因の影響分析
  • 市場機会
  • 市場の将来の動向

第4章 タンパク質治療薬:業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制の枠組みの分析

第5章 タンパク質治療薬市場:COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 タンパク質治療薬市場:情勢

  • 市場シェア分析(2021年)
  • 主要メーカー別の内訳データ
    • 確立された企業の分析
    • 新興企業の分析

第7章 タンパク質治療薬市場:治療別

  • 概要

第8章 タンパク質治療薬市場:製品別

  • 概要

第9章 タンパク質治療薬市場:機能別

  • 概要

第10章 タンパク質治療薬市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第11章 ベンダー分析

  • 競合ダッシュボード
  • 企業プロファイル
    • Amgen Inc.
    • Sanofi SA
    • Abbott Laboratories
    • Abbvie Inc.
    • Baxter International Inc.
    • Biogen Inc.
    • Csl Behring LLC
    • Eli Lilly and Company
    • F. Hoffmann-La Roche AG
    • Johnson &Johnson
    • Merck &Co. Inc.
    • Novo Nordisk A/S
    • Sereno SA
    • Novartis
    • Pfizer Inc

第12章 アナリストの包括的展望

第13章 付録

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Protein Therapeutics Market: Therapy Snapshot (2021)
  • TABLE Segment Dashboard; Definition and Scope, by Therapy
  • TABLE Global Protein Therapeutics Market, by Therapy 2017-2028 (USD Million)
  • TABLE Protein Therapeutics Market: Product Snapshot (2021)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Protein Therapeutics Market, by Product 2017-2028 (USD Million)
  • TABLE Protein Therapeutics Market: Regional snapshot (2021)
  • TABLE Protein Therapeutics Market: Function Snapshot (2021)
  • TABLE Segment Dashboard; Definition and Scope, by Function
  • TABLE Global Protein Therapeutics Market, by Function 2017-2028 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Protein Therapeutics Market, by Region 2017-2028 (USD Million)
  • TABLE North America Protein Therapeutics Market, by Country, 2017-2028 (USD Million)
  • TABLE North America Protein Therapeutics Market, by Therapy, 2017-2028 (USD Million)
  • TABLE North America Protein Therapeutics Market, by Product, 2017-2028 (USD Million)
  • TABLE North America Protein Therapeutics Market, by Function, 2017-2028 (USD Million)
  • TABLE Europe Protein Therapeutics Market, by Country, 2017-2028 (USD Million)
  • TABLE Europe Protein Therapeutics Market, by Therapy, 2017-2028 (USD Million)
  • TABLE Europe Protein Therapeutics Market, by Product, 2017-2028 (USD Million)
  • TABLE Europe Protein Therapeutics Market, by Function, 2017-2028 (USD Million)
  • TABLE Asia Pacific Protein Therapeutics Market, by Country, 2017-2028 (USD Million)
  • TABLE Asia Pacific Protein Therapeutics Market, by Therapy, 2017-2028 (USD Million)
  • TABLE Asia Pacific Protein Therapeutics Market, by Product, 2017-2028 (USD Million)
  • TABLE Asia Pacific Protein Therapeutics Market, by Function, 2017-2028 (USD Million)
  • TABLE Latin America Protein Therapeutics Market, by Country, 2017-2028 (USD Million)
  • TABLE Latin America Protein Therapeutics Market, by Therapy, 2017-2028 (USD Million)
  • TABLE Latin America Protein Therapeutics Market, by Product, 2017-2028 (USD Million)
  • TABLE Latin America Protein Therapeutics Market, by Function, 2017-2028 (USD Million)
  • TABLE Middle East and Africa Protein Therapeutics Market, by Country, 2017-2028 (USD Million)
  • TABLE Middle East and Africa Protein Therapeutics Market, by Therapy, 2017-2028 (USD Million)
  • TABLE Middle East and Africa Protein Therapeutics Market, by Product, 2017-2028 (USD Million)
  • TABLE Middle East and Africa Protein Therapeutics Market, by Function, 2017-2028 (USD Million)
目次
Product Code: ANV998

Reprt Highlight:

Protein Therapeutics Market size was valued at USD 290,701.8 Million in 2021, expanding at a CAGR of 8.2% from 2022 to 2028.

Protein-based therapies made synthetically are referred to as protein therapeutics. They are strong, quick-acting medications that give the body a precise dosage of tiny protein molecules. Recombinant versions of naturally occurring proteins consist of insulin, monoclonal antibodies, erythropoietin, fusion proteins, and interferon.

Market Dynamics

Due to the sharp rise in chronic disease cases and advancements in plasma-inferred medicines, protein therapeutics have seen a considerable increase in popularity, which, in turn, is expected to boost market growth. Additionally, the surge in public awareness of protein therapies promotes market growth. Protein drugs are a sizable class of medications that are permitted for the treatment of numerous disorders, including cancer and other types of malignant growth. These drugs have great potential to enhance human health. Protein therapy is a disease-treating approach that uses proteins and peptides to cure disease. Protein treatment delivers protein to the body in precise amounts (as would typically be present) to help in healing disease, treating pain, or remodeling structures. Protein therapy is similar to quality therapy but not at all like quality therapy.

Furthermore, the enormous increase in the prevalence of numerous chronic diseases including cancer, diabetes, and various cardiovascular conditions is one of the major factors driving the growth of the global market for protein therapies. The market is also seeing considerable growth due to consumers and end users becoming more aware of the advantages of protein therapies and the few risks or side effects they pose. However, due to the high expense of research and development on sophisticated biological systems capable of activating tissues, the market may face significant obstacles. Further, the COVID-19 pandemic has positively impacted the global protein therapeutics market with a growing emphasis on boosting healthcare facilities across the globe.

Segmentation Analysis:

The Global Protein Therapeutics Market is segmented on the basis of Therapy, Product, Function, and Region.

The market is split into seven categories based on Therapy: metabolic disorders, hematological disorders, immunological disorders, hormonal disorders, cancer, genetic disorders, and others. The genetic disorders segment dominates the market. Growing demand for gene detection disease is primarily contributing to segment growth.

The market is segmented into six categories based on Product: Monoclonal Antibodies (mAbs), human insulin, erythropoietin, clotting factors, fusion protein, and others. The monoclonal antibodies segment dominates the market. Growing demand for gene detection and clonal treatment of disease is primarily contributing to segment growth.

The market is segmented into four categories based on Function: enzymatic and regulatory activity, special targeting activity, vaccines, and protein diagnostics. The protein diagnostics segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the need for protein therapeutics.

Competitive Landscape:

The worldwide market for Protein Therapeutics is highly fragmented comprised of large and small-sized market players with a few large ones dominating the global market share. The companies in the market emphasize adopting aggressive strategies to reach out large consumer base. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new Therapy launches, partnerships, distribution network development, R&D spending, and mergers and acquisitions.

For instance, in January 2022, Amgen Inc. and Generate Biomedicines announced a multi-target, multi-modality research collaboration agreement to boost their medical capabilities.

Key features of the study:

  • This proposed research study on Protein Therapeutics market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2022-2028), considering 2021 as the base year
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Protein Therapeutics market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Protein Therapeutics market
  • Impact of COVID-19 on Protein Therapeutics market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Protein Therapeutics market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Protein Therapeutics market, we have also included competitive landscape and key innovator analysis for the Protein Therapeutics market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Protein Therapeutics market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Protein Therapeutics market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PROTEIN THERAPEUTICS MARKET KEY PLAYERS

  • Amgen Inc.
  • Sanofi SA
  • Abbott Laboratories
  • Abbvie Inc.
  • Baxter International Inc.
  • Biogen Inc.
  • Csl Behring L.L.C.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novo Nordisk A/S
  • Sereno SA
  • Novartis
  • Pfizer Inc

GLOBAL PROTEIN THERAPEUTICS MARKET, BY THERAPY

  • Metabolic disorders
  • Immunological disorders
  • Hematological disorders
  • Cancer
  • Hormonal disorders
  • Genetic disorders
  • Others

GLOBAL PROTEIN THERAPEUTICS MARKET, BY PRODUCT

  • Monoclonal antibodies (mAbs)
  • Human insulin
  • Erythropoietin
  • Clotting factors
  • Fusion protein
  • Others

GLOBAL PROTEIN THERAPEUTICS MARKET, BY FUNCTION

  • Enzymatic and regulatory activity
  • Special targeting activity
  • Vaccines
  • Protein diagnostics

GLOBAL PROTEIN THERAPEUTICS MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Protein Therapeutics Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Therapy
    • 2.1.2. Market Snippet by Product
    • 2.1.3. Market Snippet by Function
    • 2.1.4. Market Snippet by Country
    • 2.1.5. Market Snippet by Region
  • 2.2. Competitive Insights

3. Protein Therapeutics Key Market Trends

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. Protein Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Protein Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Protein Therapeutics Market Landscape

  • 6.1. Market Share Analysis, 2021
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Protein Therapeutics Market - By Therapy

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Therapy, 2021 & 2028 (%)
    • 7.1.2. Metabolic disorders
    • 7.1.3. Immunological disorders
    • 7.1.4. Haematological disorders
    • 7.1.5. Cancer
    • 7.1.6. Hormonal disorders
    • 7.1.7. Genetic disorders
    • 7.1.8. Others

8. Protein Therapeutics Market - By Product

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2021 & 2028 (%)
    • 8.1.2. Monoclonal antibodies (mAbs)
    • 8.1.3. Human insulin
    • 8.1.4. Erythropoietin
    • 8.1.5. Clotting factors
    • 8.1.6. Fusion protein
    • 8.1.7. Others

9. Protein Therapeutics Market - By Function

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Product, 2021 & 2028 (%)
    • 9.1.2. Enzymatic and regulatory activity
    • 9.1.3. Special targeting activity
    • 9.1.4. Vaccines
    • 9.1.5. Protein diagnostics

10. Protein Therapeutics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2021 & 2028 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Therapy, 2017 - 2028 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Function, 2017 - 2028 (US$ Million)

11. Key Vendor Analysis

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Amgen Inc.
    • 11.2.2. Sanofi SA
    • 11.2.3. Abbott Laboratories
    • 11.2.4. Abbvie Inc.
    • 11.2.5. Baxter International Inc.
    • 11.2.6. Biogen Inc.
    • 11.2.7. Csl Behring L.L.C.
    • 11.2.8. Eli Lilly and Company
    • 11.2.9. F. Hoffmann-La Roche AG
    • 11.2.10. Johnson & Johnson
    • 11.2.11. Merck & Co. Inc.
    • 11.2.12. Novo Nordisk A/S
    • 11.2.13. Sereno SA
    • 11.2.14. Novartis
    • 11.2.15. Pfizer Inc

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us